HAEM5:Systemic EBV-positive T-cell lymphoma of childhood: Difference between revisions
No edit summary |
Richard.Glen (talk | contribs) Section title fix |
||
| (4 intermediate revisions by one other user not shown) | |||
| Line 96: | Line 96: | ||
|} | |} | ||
== Gene Mutations (SNV/ | == Gene Mutations (SNV/INDEL) == | ||
Somatic mutations have been reported; however, consistent/recurrent mutations are not well-described.<ref name=":10" /> | Somatic mutations have been reported; however, consistent/recurrent mutations are not well-described.<ref name=":10" /> | ||
* ''FYN'' mutations have been reported in two cases <ref name=":10" /><ref | * ''FYN'' mutations have been reported in two cases <ref name=":10" /><ref>{{Cite journal|last=Asmussen|first=Anders|last2=Quintanilla-Martinez|first2=Leticia|last3=Larsen|first3=Martin|last4=Fagerberg|first4=Christina|last5=Bækvad-Hansen|first5=Marie|last6=Juul|first6=Maja Bech|last7=Rewers|first7=Kate|last8=Raaschou-Jensen|first8=Klas|last9=Barnkob|first9=Mike Bogetofte|date=2024-01|title=Severe lympho-depletion, abrogated thymopoiesis and systemic EBV positive T-cell lymphoma of childhood, a case|url=https://pubmed.ncbi.nlm.nih.gov/37871127|journal=Leukemia & Lymphoma|volume=65|issue=1|pages=118–122|doi=10.1080/10428194.2023.2264425|issn=1029-2403|pmid=37871127}}</ref> | ||
* Mutations in ''KMT2D'', ''MFHAS1'', ''STAT3'', ''EP300'', ''ITPKB'', ''DDX3X'', ''NOTCH1'', ''NOTCH2'', and ''TET2'' (amongst others) have also been reported | * Mutations in ''KMT2D'', ''MFHAS1'', ''STAT3'', ''EP300'', ''ITPKB'', ''DDX3X'', ''NOTCH1'', ''NOTCH2'', and ''TET2'' (amongst others) have also been reported | ||
{| class="wikitable sortable" | {| class="wikitable sortable" | ||
| Line 115: | Line 115: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
|} | |} | ||
== Epigenomic Alterations == | == Epigenomic Alterations == | ||
N/A | N/A | ||
| Line 156: | Line 155: | ||
== References == | == References == | ||
<references /> | <references /> | ||
== Notes == | == Notes == | ||
[[Category:HAEM5]] | |||
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the [[Leadership|''<u>Associate Editor</u>'']] or other CCGA representative. When pages have a major update, the new author will be acknowledged at the beginning of the page, and those who contributed previously will be acknowledged below as a prior author. | <nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the [[Leadership|''<u>Associate Editor</u>'']] or other CCGA representative. When pages have a major update, the new author will be acknowledged at the beginning of the page, and those who contributed previously will be acknowledged below as a prior author. | ||
Prior Author(s): Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA | Prior Author(s): Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA | ||
''Citation of this Page'': Miller K. “Systemic EBV-positive T-cell lymphoma of childhood”. Compendium of Cancer Genome Aberrations (CCGA), Cancer Genomics Consortium (CGC), updated {{REVISIONMONTH}}/{{REVISIONDAY}}/{{REVISIONYEAR}}, <nowiki>https://ccga.io/index.php/HAEM5:Systemic_EBV-positive_T-cell_lymphoma_of_childhood</nowiki>.<center> | |||
<center> | |||
[[Category:HAEM5]] | [[Category:HAEM5]] | ||
[[Category:DISEASE]] | |||
[[Category:Diseases S]] | |||
[[Category:DISEASE]] | [[Category:DISEASE]] | ||
[[Category:Diseases S]] | [[Category:Diseases S]] | ||